image credit: Commander / Flickr

FDA OK’s third dose of Moderna’s COVID-19 vaccine for immunocompromised

August 16, 2021


Specifically, the FDA has cleared a third booster dose for immunocompromised individuals aged 18 years or older, who have undergone solid organ transplantation, or who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise.

“We recognise the need to protect immunocompromised individuals who are at the highest risk of severe COVID-19 disease,” said Stéphane Bancel, chief executive officer of Moderna.

Read More on Pharma Times